Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Haematologica|September 21, 2023
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemiaYuta Kaito, Emi Sugimoto, Fumi Nakamura, et al.
American Journal of Hematology|July 25, 2006
Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignanciesKumi Oshima, Yoshinobu Kanda, Fumio Nakahara, et al.
Blood|February 4, 2011
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteinsAkihide Yoshimi, Susumu Goyama, Naoko Watanabe-Okochi, et al.
The Journal of Biological Chemistry|January 31, 2004
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residuesYuko Yamaguchi, Mineo Kurokawa, Yoichi Imai, et al.
European Journal of Immunology|April 26, 2012
Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiationMayumi Yoshimi, Susumu Goyama, Masahito Kawazu, et al.
Blood|October 25, 2011
AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumorsMasahiro Nakagawa, Munetake Shimabe, Naoko Watanabe-Okochi, et al.
The Journal of Experimental Medicine|November 16, 2011
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activityKeisuke Kataoka, Tomohiko Sato, Akihide Yoshimi, et al.
International Journal of Hematology|March 17, 2023
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)Fumi Nakamura, Sachiko Seo, Yasuhito Nannya, et al.
Physics in Medicine and Biology|January 3, 2025
A whole gamma imaging prototype for higher quantitative imaging of89Zr-labeled antibodies in a tumor mouse modelSodai Takyu, Hideaki Tashima, Miwako Takahashi, et al.
Ejhaem|July 18, 2022
RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axisHirohito Kubota, Tatsuya Masuda, Mina Noura, et al.
Pageof 9